CN105699473B - 胃癌唾液蛋白指纹图谱分子诊断模型建立方法 - Google Patents
胃癌唾液蛋白指纹图谱分子诊断模型建立方法 Download PDFInfo
- Publication number
- CN105699473B CN105699473B CN201610169314.3A CN201610169314A CN105699473B CN 105699473 B CN105699473 B CN 105699473B CN 201610169314 A CN201610169314 A CN 201610169314A CN 105699473 B CN105699473 B CN 105699473B
- Authority
- CN
- China
- Prior art keywords
- gastric cancer
- group
- saliva
- chronic gastritis
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010017758 gastric cancer Diseases 0.000 title claims abstract description 78
- 208000005718 Stomach Neoplasms Diseases 0.000 title claims abstract description 77
- 201000011549 stomach cancer Diseases 0.000 title claims abstract description 77
- 238000000034 method Methods 0.000 title claims abstract description 45
- 102000007365 Sialoglycoproteins Human genes 0.000 title claims abstract description 17
- 108010032838 Sialoglycoproteins Proteins 0.000 title claims abstract description 17
- 208000007882 Gastritis Diseases 0.000 claims abstract description 53
- 208000023652 chronic gastritis Diseases 0.000 claims abstract description 46
- 210000003296 saliva Anatomy 0.000 claims abstract description 44
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 39
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 39
- 239000011324 bead Substances 0.000 claims abstract description 14
- 230000035945 sensitivity Effects 0.000 claims abstract description 13
- 238000007405 data analysis Methods 0.000 claims abstract description 7
- 238000011068 loading method Methods 0.000 claims abstract description 5
- 230000008569 process Effects 0.000 claims abstract description 5
- 238000010183 spectrum analysis Methods 0.000 claims abstract description 3
- 230000014509 gene expression Effects 0.000 claims description 33
- 239000006228 supernatant Substances 0.000 claims description 17
- 239000000090 biomarker Substances 0.000 claims description 13
- 239000011534 wash buffer Substances 0.000 claims description 10
- 238000010828 elution Methods 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 238000003066 decision tree Methods 0.000 claims description 6
- 230000004069 differentiation Effects 0.000 claims description 6
- 210000002784 stomach Anatomy 0.000 claims description 6
- 229910000831 Steel Inorganic materials 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 239000010959 steel Substances 0.000 claims description 5
- NZNMSOFKMUBTKW-UHFFFAOYSA-N Cyclohexanecarboxylic acid Natural products OC(=O)C1CCCCC1 NZNMSOFKMUBTKW-UHFFFAOYSA-N 0.000 claims description 4
- AFVLVVWMAFSXCK-VMPITWQZSA-N alpha-cyano-4-hydroxycinnamic acid Chemical compound OC(=O)C(\C#N)=C\C1=CC=C(O)C=C1 AFVLVVWMAFSXCK-VMPITWQZSA-N 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 230000008859 change Effects 0.000 claims description 3
- 229940079593 drug Drugs 0.000 claims description 3
- 239000012149 elution buffer Substances 0.000 claims description 3
- 235000013305 food Nutrition 0.000 claims description 3
- 230000008014 freezing Effects 0.000 claims description 3
- 238000007710 freezing Methods 0.000 claims description 3
- 238000011534 incubation Methods 0.000 claims description 3
- 239000006166 lysate Substances 0.000 claims description 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 3
- 230000001105 regulatory effect Effects 0.000 claims description 3
- 239000012047 saturated solution Substances 0.000 claims description 3
- 230000009747 swallowing Effects 0.000 claims description 3
- 238000010257 thawing Methods 0.000 claims description 3
- 210000004885 white matter Anatomy 0.000 claims description 3
- 108010033040 Histones Proteins 0.000 claims description 2
- 239000012895 dilution Substances 0.000 claims description 2
- 238000010790 dilution Methods 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 239000011259 mixed solution Substances 0.000 claims description 2
- 230000001681 protective effect Effects 0.000 claims description 2
- 229920001184 polypeptide Polymers 0.000 claims 1
- 230000001376 precipitating effect Effects 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 abstract description 17
- 238000005516 engineering process Methods 0.000 abstract description 9
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 abstract description 5
- 238000006467 substitution reaction Methods 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 3
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 230000009610 hypersensitivity Effects 0.000 abstract 1
- 208000016644 chronic atrophic gastritis Diseases 0.000 description 9
- 208000004300 Atrophic Gastritis Diseases 0.000 description 8
- 208000036495 Gastritis atrophic Diseases 0.000 description 8
- 206010028980 Neoplasm Diseases 0.000 description 7
- 238000001514 detection method Methods 0.000 description 7
- 238000011160 research Methods 0.000 description 7
- 238000012216 screening Methods 0.000 description 7
- 230000001684 chronic effect Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000002496 gastric effect Effects 0.000 description 5
- 238000007689 inspection Methods 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 4
- 238000011835 investigation Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 210000004907 gland Anatomy 0.000 description 3
- 238000001869 matrix assisted laser desorption--ionisation mass spectrum Methods 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- AOXOCDRNSPFDPE-UKEONUMOSA-N chembl413654 Chemical compound C([C@H](C(=O)NCC(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@@H](N)CCC(O)=O)C1=CC=C(O)C=C1 AOXOCDRNSPFDPE-UKEONUMOSA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 208000009458 Carcinoma in Situ Diseases 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 208000027205 Congenital disease Diseases 0.000 description 1
- 208000029767 Congenital, Hereditary, and Neonatal Diseases and Abnormalities Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 201000003883 Cystic fibrosis Diseases 0.000 description 1
- 241001269238 Data Species 0.000 description 1
- 101710198144 Endopolygalacturonase I Proteins 0.000 description 1
- 102100021022 Gastrin Human genes 0.000 description 1
- 108010052343 Gastrins Proteins 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010054949 Metaplasia Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 108700020796 Oncogene Proteins 0.000 description 1
- 208000006994 Precancerous Conditions Diseases 0.000 description 1
- 101710191566 Probable endopolygalacturonase I Proteins 0.000 description 1
- 108010026552 Proteome Proteins 0.000 description 1
- 208000021386 Sjogren Syndrome Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000009956 adenocarcinoma Diseases 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 208000010749 gastric carcinoma Diseases 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 201000004933 in situ carcinoma Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- HCZHHEIFKROPDY-UHFFFAOYSA-N kynurenic acid Chemical compound C1=CC=C2NC(C(=O)O)=CC(=O)C2=C1 HCZHHEIFKROPDY-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 210000003079 salivary gland Anatomy 0.000 description 1
- 201000000498 stomach carcinoma Diseases 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
- G01N33/6851—Methods of protein analysis involving laser desorption ionisation mass spectrometry
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Hematology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Optics & Photonics (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
组别 | 例数 | 正确诊断(例) | 错误诊断(例) | 正确率(%) |
胃癌组 | 57 | 55 | 2 | 96 |
慢性胃炎组 | 28 | 24 | 4 | 86 |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610169314.3A CN105699473B (zh) | 2016-03-23 | 2016-03-23 | 胃癌唾液蛋白指纹图谱分子诊断模型建立方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610169314.3A CN105699473B (zh) | 2016-03-23 | 2016-03-23 | 胃癌唾液蛋白指纹图谱分子诊断模型建立方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105699473A CN105699473A (zh) | 2016-06-22 |
CN105699473B true CN105699473B (zh) | 2018-11-06 |
Family
ID=56231729
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610169314.3A Active CN105699473B (zh) | 2016-03-23 | 2016-03-23 | 胃癌唾液蛋白指纹图谱分子诊断模型建立方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105699473B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106950380B (zh) * | 2017-03-02 | 2019-01-11 | 江苏先思达生物科技有限公司 | 一种胃癌监测试剂盒及其使用方法 |
CN110880356A (zh) * | 2018-09-05 | 2020-03-13 | 南京格致基因生物科技有限公司 | 对卵巢癌进行筛查、诊断或风险分级的方法和装置 |
CN110220965B (zh) * | 2019-07-17 | 2020-05-22 | 山东省分析测试中心 | 一种快速鉴别反复冻融肉类的方法 |
CN113466465A (zh) * | 2021-01-20 | 2021-10-01 | 浙江大学滨海产业技术研究院 | 一种基于蛋白质组学的唾液检测方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104007166A (zh) * | 2014-05-29 | 2014-08-27 | 深圳市第二人民医院 | 一种慢性胃炎诊断的唾液蛋白诊断模型及其构建方法 |
CN104007169A (zh) * | 2014-05-29 | 2014-08-27 | 深圳市第二人民医院 | 一种胃癌的唾液蛋白诊断模型及其建立方法 |
CN104515797A (zh) * | 2014-05-29 | 2015-04-15 | 深圳市第二人民医院 | 乳腺癌早期诊断的唾液蛋白指纹图谱模型及其构建方法 |
-
2016
- 2016-03-23 CN CN201610169314.3A patent/CN105699473B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104007166A (zh) * | 2014-05-29 | 2014-08-27 | 深圳市第二人民医院 | 一种慢性胃炎诊断的唾液蛋白诊断模型及其构建方法 |
CN104007169A (zh) * | 2014-05-29 | 2014-08-27 | 深圳市第二人民医院 | 一种胃癌的唾液蛋白诊断模型及其建立方法 |
CN104515797A (zh) * | 2014-05-29 | 2015-04-15 | 深圳市第二人民医院 | 乳腺癌早期诊断的唾液蛋白指纹图谱模型及其构建方法 |
Non-Patent Citations (1)
Title |
---|
基于唾液蛋白质组学的2型糖尿病病证结合分子诊断模型研究;杨长青;《万方数据》;20151229;摘要,论文第6-13页1.1-3.7节、4.2节,图5-1 * |
Also Published As
Publication number | Publication date |
---|---|
CN105699473A (zh) | 2016-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105699473B (zh) | 胃癌唾液蛋白指纹图谱分子诊断模型建立方法 | |
CN105506115B (zh) | 一种检测诊断遗传性心肌病致病基因的dna文库及其应用 | |
Bielanski et al. | New approach to 13C-urea breath test: capsule-based modification with low-dose of 13C-urea in the diagnosis of Helicobacter pylori infection | |
AU2011241174B2 (en) | Method and kit for cancer diagnosis | |
CN109557311B (zh) | 结直肠癌诊断标志物及结直肠癌的检测产品及其应用 | |
WO2018157831A1 (zh) | 一种肺癌监测试剂盒及其使用方法 | |
CN112599197B (zh) | 一种基于血浆dna片段分析评估患癌风险的方法和装置 | |
CN109470859A (zh) | 一种外泌体蛋白作为鉴别肺结节良恶性标志物及其应用 | |
CN105793710A (zh) | 用于肺癌诊断的组合物、方法和试剂盒 | |
CN107904286A (zh) | 一种结直肠癌微生物标志物及其应用 | |
CN108866196A (zh) | 一种用于人结直肠肿瘤特异性甲基化检测的引物和探针、试剂盒及其应用 | |
CN105842327B (zh) | 胃癌脾虚证唾液蛋白指纹图谱分子诊断模型建立方法 | |
KR101223270B1 (ko) | 대장암 진단용 저질량 이온 결정 방법, 이를 이용하여 대장암 진단을 위한 정보를 제공하는 방법, 및 이를 위한 연산 장치 | |
CN101685080B (zh) | 一种生物样品中蛋白质组的分析方法 | |
CN105628784B (zh) | 大肠癌唾液蛋白指纹图谱分子诊断模型建立方法 | |
CN108334747B (zh) | 获取肿瘤尿蛋白标志物的方法及得到的肿瘤相关离群尿蛋白库 | |
CN109975548A (zh) | IgG4检测试剂在制备结直肠癌诊断剂方面的应用 | |
CN111751551B (zh) | 蛋白分子作为诊断肝硬化的生物标志物及其预后方法 | |
CN108070656A (zh) | 肺癌标志物及其应用 | |
WO2021183859A9 (en) | Biomarkers for clear cell renal cell carcinoma | |
DE10101792A1 (de) | Verfahren zum Nachweis pankreatitischer und gastrointestinaler Erkrankungen | |
WO2003036301A1 (fr) | Procede d'evaluation de cancer au moyen de marqueurs tumoraux | |
Patil et al. | To assess calretinin immunohistochemistry in Hirschsprung’s disease and allied disorders | |
CN113447586B (zh) | 一种用于贲门癌筛查的标志物及检测试剂盒 | |
CN117310059B (zh) | 用于早期诊断或监测克罗恩病的血浆代谢标志物组合及应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240422 Address after: No. 3002 Sungang West Road, Huafu Street, Futian District, Shenzhen City, Guangdong Province, 518032 Patentee after: Shenzhen Second People's Hospital (Shenzhen Institute of translational medicine) Country or region after: China Address before: 518020 No. 1017 Dongmen North Road, Shenzhen, Guangdong, Luohu District Patentee before: SHENZHEN INSTITUTE OF GERIATRICS Country or region before: China Patentee before: Wu Zhengzhi |
|
TR01 | Transfer of patent right |